Thank for this..Expansion mentioned(hinted) through commercialiation and revenues for 2016
Several agrochemical companies have turned to ADNAS to protect chemical products from counterfeiting through SigNature T. “Our DNA platform is also relevant to tracing pharmaceuticals, food, and chemicals,” says MeiLin Wan, vice president of Textile Sales with ADNAS
Same here..just like nialls.Prior to 60:1 factors here. Did more than 20 or 30 purchases after my intial one.Did not sell single share till now.Even when it rose to $9 tempted to sell some but did not. Very long player her.e GLALL
This 2 yrs trial project is still dues by August 2016.No extension.
One year extension was given (till November 2016 from December 2015) for that contract of marking microcuits in house and to provide training etc for DLA. This is totally unrelated to 2 yr trial project for marking hi risk components for DLA
End of August is the end of our initial trial period that has just been extended
You cant ignore DLA. If positive, It will make huge impact in revenues. Can you guess how much company can make if all goes as expected from trial project that ends in August?
Isn't that extension (one year from December 2015) related to DNA marking in house for electronics??
Minimum of recurring $30 million per year
naills, Thanks for finding this. Increases hope for expansion in August
Why buy this POS.Move on to other stocks. This is not even worth 10 cents.Junk stock..Measely 500k and $4 million in spending.
Unless they get the mandate expansion for both MDA and DLA, company cannot survive, Dr says all C and B stories and keep and saying. Can't trust him anymore.